Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05036629 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Development of MRI Protocols and Associated Neuro-physiological Explorations in Healthy and Pathological Subjects

Study acronym: MAP-IRMaGE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 years later Sep 8, 2026 → Sep 8, 2031
See other at-risk trials from University Hospital, Grenoble

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Sep 8, 2026 to Sep 8, 2031
    • Trial status changed: Unknown → Recruiting
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 1 of 5 entries
  2. Changed Registry marked status Unknown; last known: Recruiting
  3. Trial status: Recruiting to Unknownv4
  4. Re-verified, no change to tracked fieldsv3
  5. Lead sponsor: AdministrateurDRC to University Hospital, Grenoblev2 Show 4 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Sep 26, 2026 to Sep 8, 2026
    • Start date changed from estimate of Sep 2021 to Sep 9, 2021
    • Site details revised
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
IRMaGe is a Joint Service Unit (UMS) which provides users of brain exploration equipment (clinical MRI and preclinical, TMS, EEG, NIRS and metabolomics). The methods available on this equipment are intended to evolve according to the most recent discoveries and this protocol aims to frame the developments necessary around clinical MRI for IRMaGe can continue to offer tools at the cutting edge of technology.
Trial Details
NCT Number NCT05036629
Lead Sponsor University Hospital, Grenoble
Conditions
(from sponsor)		 MRI, Sequence Optimization, Physiological Measurement
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov